The DOI matches its Crossref record; 152 of the 152 references it cites were found in a registry or an index.
Dietary Fructose and the Metabolic Syndrome
Open accessAbstract
Consumption of fructose, the sweetest of all naturally occurring carbohydrates, has increased dramatically in the last 40 years and is today commonly used commercially in soft drinks, juice, and baked goods. These products comprise a large proportion of the modern diet, in particular in children, adolescents, and young adults. A large body of evidence associate consumption of fructose and other sugar-sweetened beverages with insulin resistance, intrahepatic lipid accumulation, and hypertriglyceridemia. In the long term, these risk factors may contribute to the development of type 2 diabetes and cardiovascular diseases. Fructose is absorbed in the small intestine and metabolized in the liver where it stimulates fructolysis, glycolysis, lipogenesis, and glucose production. This may result in hypertriglyceridemia and fatty liver. Therefore, understanding the mechanisms underlying intestinal and hepatic fructose metabolism is important. Here we review recent evidence linking excessive fructose consumption to health risk markers and development of components of the Metabolic Syndrome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The metabolic phenotype in obesity: Fat mass, body fat distribution, and adipose tissue function
Goossens, G. H. (2017) · Obesity Facts · doi:10.1159/000471488 · Cited by 8,481
Health effects of overweight and obesity in 195 countries over 25 years
Collaborators, T. G. 2. O. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1614362 · Cited by 7,918
Obesity: global epidemiology and pathogenesis
Blüher, M. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0176-8 · Cited by 5,126
EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
(2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.11.004 · Cited by 4,836
Vernon, G., Baranova, A., & Younossi, Z. M. (2011) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04724.x · Cited by 3,074
Non-alcoholic fatty liver disease - a global public health perspective
Younossi, Z. M. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2018.10.033 · Cited by 2,149
Estes, C., Anstee, Q. M., Arias-Loste, M. T., Bantel, H., Bellentani, S., Caballeria, J., Colombo, M., Craxi, A., Crespo, J., Day, C. P., et al. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.05.036 · Cited by 1,980
Global perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
Younossi, Z., Tacke, F., Arrese, M., Chander Sharma, B., Mostafa, I., Bugianesi, E., Wai‐Sun Wong, V., Yilmaz, Y., George, J., Fan, J., et al. (2019) · Hepatology · doi:10.1002/hep.30251 · Cited by 1,858 · cited 2×
“Accumulating evidence indicates that increased hepatic DNL is a significant pathway contributing to the development of NAFLD [6,46].”
BackgroundStanhope, K. L., Schwarz, J. M., Keim, N. L., Griffen, S. C., Bremer, A. A., Graham, J. L., Hatcher, B., Cox, C. L., Dyachenko, A., Zhang, W., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37385 · Cited by 1,765
Szczepaniak, L. S., Nurenberg, P., Leonard, D., Browning, J. D., Reingold, J. S., Grundy, S., Hobbs, H. H., & Dobbins, R. L. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00064.2004 · Cited by 1,562
Metabolic Effects of Fructose and the Worldwide Increase in Obesity
Tappy, L., & Lê, K.-A. (2010) · Physiological Reviews · doi:10.1152/physrev.00019.2009 · Cited by 1,256
Epidemiology of Non-Alcoholic Fatty Liver Disease
Bellentani, S., Scaglioni, F., Marino, M., & Bedogni, G. (2010) · Digestive Diseases · doi:10.1159/000282080 · Cited by 1,026
Vos, M. B., Abrams, S. H., Barlow, S. E., Caprio, S., Daniels, S. R., Kohli, R., Mouzaki, M., Sathya, P., Schwimmer, J. B., Sundaram, S. S., et al. (2017) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000001482 · Cited by 1,008
Regulation of Hepatic Lipogenesis by the Transcription Factor XBP1
Lee, A.-H., Scapa, E. F., Cohen, D. E., & Glimcher, L. H. (2008) · Science · doi:10.1126/science.1158042 · Cited by 977
Endoplasmic reticulum stress signalling and the pathogenesis of non-alcoholic fatty liver disease
Lebeaupin, C., Vallée, D., Hazari, Y., Hetz, C., Chevet, E., & Bailly-Maitre, B. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.06.008 · Cited by 944
Fructose and sugar: A major mediator of non-alcoholic fatty liver disease
Jensen, T., Abdelmalek, M. F., Sullivan, S., Nadeau, K. J., Green, M., Roncal, C., Nakagawa, T., Kuwabara, M., Sato, Y., Kang, D.-H., et al. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.01.019 · Cited by 941
Dhingra, R., Sullivan, L., Jacques, P. F., Wang, T. J., Fox, C. S., Meigs, J. B., D’Agostino, R. B., Gaziano, J. M., & Vasan, R. S. (2007) · Circulation · doi:10.1161/circulationaha.107.689935 · Cited by 918
Facchini, F. (1991) · JAMA · doi:10.1001/jama.1991.03470210076036 · Cited by 885
Neeland, I. J., Poirier, P., & Després, J.-P. (2018) · Circulation · doi:10.1161/circulationaha.117.029617 · Cited by 881
Fructose consumption as a risk factor for non-alcoholic fatty liver disease
Ouyang, X., Cirillo, P., Sautin, Y., McCall, S., Bruchette, J. L., Diehl, A. M., Johnson, R. J., & Abdelmalek, M. F. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.02.011 · Cited by 863
Stefan, N., Häring, H.-U., & Cusi, K. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30154-2 · Cited by 837
Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy
Reeder, S. B., Cruite, I., Hamilton, G., & Sirlin, C. B. (2011) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.22580 · Cited by 822
Sugar, Uric Acid, and the Etiology of Diabetes and Obesity
Johnson, R. J., Nakagawa, T., Sanchez-Lozada, L. G., Shafiu, M., Sundaram, S., Le, M., Ishimoto, T., Sautin, Y. Y., & Lanaspa, M. A. (2013) · Diabetes · doi:10.2337/db12-1814 · Cited by 760
Intestinal microbiota in patients with nonalcoholic fatty liver disease
Mouzaki, M., Comelli, E. M., Arendt, B. M., Bonengel, J., Fung, S. K., Fischer, S. E., McGilvray, I. D., & Allard, J. P. (2013) · Hepatology · doi:10.1002/hep.26319 · Cited by 749
Sugar consumption, metabolic disease and obesity: The state of the controversy
Stanhope, K. L. (2016) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408363.2015.1084990 · Cited by 739
Uric Acid Induces Hepatic Steatosis by Generation of Mitochondrial Oxidative Stress
Lanaspa, M. A., Sanchez-Lozada, L. G., Choi, Y.-J., Cicerchi, C., Kanbay, M., Roncal-Jimenez, C. A., Ishimoto, T., Li, N., Marek, G., Duranay, M., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.399899 · Cited by 710
Role of Dietary Fructose and Hepatic De Novo Lipogenesis in Fatty Liver Disease
Softic, S., Cohen, D. E., & Kahn, C. R. (2016) · Digestive Diseases and Sciences · doi:10.1007/s10620-016-4054-0 · Cited by 709
EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD), & European Association for the Study of Obesity (EASO) (2016) · Diabetologia · doi:10.1007/s00125-016-3902-y · Cited by 683
The Small Intestine Converts Dietary Fructose into Glucose and Organic Acids
Jang, C., Hui, S., Lu, W., Cowan, A. J., Morscher, R. J., Lee, G., Liu, W., Tesz, G. J., Birnbaum, M. J., & Rabinowitz, J. D. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2017.12.016 · Cited by 639
Gut-derived short-chain fatty acids are vividly assimilated into host carbohydrates and lipids
den Besten, G., Lange, K., Havinga, R., van Dijk, T. H., Gerding, A., van Eunen, K., Müller, M., Groen, A. K., Hooiveld, G. J., Bakker, B. M., et al. (2013) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00265.2013 · Cited by 605
Maersk, M., Belza, A., Stødkilde-Jørgensen, H., Ringgaard, S., Chabanova, E., Thomsen, H., Pedersen, S. B., Astrup, A., & Richelsen, B. (2012) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.111.022533 · Cited by 603
Prevalence of the Metabolic Syndrome in Individuals with Hyperuricemia
Choi, H. K., & Ford, E. S. (2007) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.06.040 · Cited by 601
Soft drinks, fructose consumption, and the risk of gout in men: prospective cohort study
Choi, H. K., & Curhan, G. (2008) · BMJ · doi:10.1136/bmj.39449.819271.be · Cited by 577
Fructose metabolism and metabolic disease
Hannou, S. A., Haslam, D. E., McKeown, N. M., & Herman, M. A. (2018) · Journal of Clinical Investigation · doi:10.1172/jci96702 · Cited by 561
Biology of upper-body and lower-body adipose tissue—link to whole-body phenotypes.
Karpe, F., & Pinnick, K. E. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.185 · Cited by 543
Causes and Metabolic Consequences of Fatty Liver
Stefan, N., Kantartzis, K., & Häring, H.-U. (2008) · Endocrine Reviews · doi:10.1210/er.2008-0009 · Cited by 532
Mardinoglu, A., Wu, H., Bjornson, E., Zhang, C., Hakkarainen, A., Räsänen, S. M., Lee, S., Mancina, R. M., Bergentall, M., Pietiläinen, K. H., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.01.005 · Cited by 453
Self-citationDietary fat and carbohydrates differentially alter insulin sensitivity during caloric restriction
Kirk, E., Reeds, D. N., Finck, B. N., Mayurranjan, M. S., Patterson, B. W., & Klein, S. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.01.048 · Cited by 440
Nonalcoholic Fatty Liver Disease and the Heart
Stahl, E. P., Dhindsa, D. S., Lee, S. K., Sandesara, P. B., Chalasani, N. P., & Sperling, L. S. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.11.050 · Cited by 439
Luukkonen, P. K., Sädevirta, S., Zhou, Y., Kayser, B., Ali, A., Ahonen, L., Lallukka, S., Pelloux, V., Gaggini, M., Jian, C., et al. (2018) · Diabetes Care · doi:10.2337/dc18-0071 · Cited by 428
Malik, V. S., Li, Y., Pan, A., De Koning, L., Schernhammer, E., Willett, W. C., & Hu, F. B. (2019) · Circulation · doi:10.1161/circulationaha.118.037401 · Cited by 421
Uric acid in metabolic syndrome: From an innocent bystander to a central player
Kanbay, M., Jensen, T., Solak, Y., Le, M., Roncal-Jimenez, C., Rivard, C., Lanaspa, M. A., Nakagawa, T., & Johnson, R. J. (2016) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2015.11.026 · Cited by 419
Fructose and Cardiometabolic Health
Malik, V. S., & Hu, F. B. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.08.025 · Cited by 408
Mitochondrial metabolism mediates oxidative stress and inflammation in fatty liver
Satapati, S., Kucejova, B., Duarte, J. A. G., Fletcher, J. A., Reynolds, L., Sunny, N. E., He, T., Nair, L. A., Livingston, K., Fu, X., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci82204 · Cited by 399
Faeh, D., Minehira, K., Schwarz, J.-M., Periasamy, R., Park, S., & Tappy, L. (2005) · Diabetes · doi:10.2337/diabetes.54.7.1907 · Cited by 386
Lee, S. S., Park, S. H., Kim, H. J., Kim, S. Y., Kim, M.-Y., Kim, D. Y., Suh, D. J., Kim, K. M., Bae, M. H., Lee, J. Y., et al. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.01.008 · Cited by 372
Lê, K.-A., Ith, M., Kreis, R., Faeh, D., Bortolotti, M., Tran, C., Boesch, C., & Tappy, L. (2009) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2008.27336 · Cited by 369
Sugar-Sweetened Beverages, Serum Uric Acid, and Blood Pressure in Adolescents
Nguyen, S., Choi, H. K., Lustig, R. H., & Hsu, C.-Y. (2009) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2009.01.015 · Cited by 367
Fructose Consumption, Lipogenesis, and Non-Alcoholic Fatty Liver Disease
Ter Horst, K., & Serlie, M. (2017) · Nutrients · doi:10.3390/nu9090981 · Cited by 365
Divergent effects of glucose and fructose on hepatic lipogenesis and insulin signaling
Softic, S., Gupta, M. K., Wang, G.-X., Fujisaka, S., O’Neill, B. T., Rao, T. N., Willoughby, J., Harbison, C., Fitzgerald, K., Ilkayeva, O., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci94585 · Cited by 347
FRUCTOSE-INDUCED HYPERURICÆMIA
Stirpe, F., Della Corte, E., Bonetti, E., Abbondanza, A., Abbati, A., & De Stefano, F. (1970) · The Lancet · doi:10.1016/s0140-6736(70)92269-5 · Cited by 333
Chiu, S., Sievenpiper, J. L., de Souza, R. J., Cozma, A. I., Mirrahimi, A., Carleton, A. J., Ha, V, Di Buono, M., Jenkins, A. L., Leiter, L. A., et al. (2014) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2014.8 · Cited by 314
Dietary fructose in nonalcoholic fatty liver disease
Vos, M. B., & Lavine, J. E. (2013) · Hepatology · doi:10.1002/hep.26299 · Cited by 314
Fructose-Rich Beverages and Risk of Gout in Women
Choi, H. K., Willett, W., & Curhan, G. (2010) · JAMA · doi:10.1001/jama.2010.1638 · Cited by 314
Fructose metabolism in humans – what isotopic tracer studies tell us
Sun, S. Z., & Empie, M. W. (2012) · Nutrition & Metabolism · doi:10.1186/1743-7075-9-89 · Cited by 311
Haufe, S., Engeli, S., Kast, P., Böhnke, J., Utz, W., Haas, V., Hermsdorf, M., Mähler, A., Wiesner, S., Birkenfeld, A. L., et al. (2011) · Hepatology · doi:10.1002/hep.24242 · Cited by 307
Fructose and NAFLD: The Multifaceted Aspects of Fructose Metabolism
Jegatheesan, P., & De Bandt, J. (2017) · Nutrients · doi:10.3390/nu9030230 · Cited by 280
Caloric Sweetener Consumption and Dyslipidemia Among US Adults
Welsh, J. A. (2010) · JAMA · doi:10.1001/jama.2010.449 · Cited by 276
Real-world data reveal a diagnostic gap in non-alcoholic fatty liver disease
Alexander, M., Loomis, A. K., Fairburn-Beech, J., van der Lei, J., Duarte-Salles, T., Prieto-Alhambra, D., Ansell, D., Pasqua, A., Lapi, F., Rijnbeek, P., et al. (2018) · BMC Medicine · doi:10.1186/s12916-018-1103-x · Cited by 272
Stanhope, K. L., Medici, V., Bremer, A. A., Lee, V., Lam, H. D., Nunez, M. V., Chen, G. X., Keim, N. L., & Havel, P. J. (2015) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.114.100461 · Cited by 270
Haidari, M., Leung, N., Mahbub, F., Uffelman, K. D., Kohen-Avramoglu, R., Lewis, G. F., & Adeli, K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200544200 · Cited by 269
Yuan, H., Yu, C., Li, X., Sun, L., Zhu, X., Zhao, C., Zhang, Z., & Yang, Z. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2527 · Cited by 266
Schwarz, J.-M., Noworolski, S. M., Erkin-Cakmak, A., Korn, N. J., Wen, M. J., Tai, V. W., Jones, G. M., Palii, S. P., Velasco-Alin, M., Pan, K., et al. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.05.043 · Cited by 266
Livesey, G., & Taylor, R. (2008) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2007.25700 · Cited by 265
Association of serum uric acid level with non-alcoholic fatty liver disease: A cross-sectional study
Li, Y., Xu, C., Yu, C., Xu, L., & Miao, M. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2008.11.021 · Cited by 264
Chung, M., Ma, J., Patel, K., Berger, S., Lau, J., & Lichtenstein, A. H. (2014) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.114.086314 · Cited by 253
FRUCTOSE-INDUCED HYPERURICÆMIA
Perheentupa, J., & Raivio, K. (1967) · The Lancet · doi:10.1016/s0140-6736(67)90494-1 · Cited by 251
The Sweet Path to Metabolic Demise: Fructose and Lipid Synthesis
Herman, M. A., & Samuel, V. T. (2016) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2016.06.005 · Cited by 247
Fructose and the Metabolic Syndrome: Pathophysiology and Molecular Mechanisms
Rutledge, A. C., & Adeli, K. (2008) · Nutrition Reviews · doi:10.1111/j.1753-4887.2007.tb00322.x · Cited by 240
Fructose Intake, Serum Uric Acid, and Cardiometabolic Disorders: A Critical Review
Caliceti, C., Calabria, D., Roda, A., & Cicero, A. (2017) · Nutrients · doi:10.3390/nu9040395 · Cited by 236
Sweet Sixteenth for ChREBP: Established Roles and Future Goals
Abdul-Wahed, A., Guilmeau, S., & Postic, C. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.07.004 · Cited by 231
Effect of a High-Fructose Weight-Maintaining Diet on Lipogenesis and Liver Fat
Schwarz, J.-M., Noworolski, S. M., Wen, M. J., Dyachenko, A., Prior, J. L., Weinberg, M. E., Herraiz, L. A., Tai, V. W., Bergeron, N., Bersot, T. P., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3678 · Cited by 229
Oh, J.-H., Alexander, L. M., Pan, M., Schueler, K. L., Keller, M. P., Attie, A. D., Walter, J., & van Pijkeren, J.-P. (2019) · Cell Host & Microbe · doi:10.1016/j.chom.2018.11.016 · Cited by 229
Role of Fructose-Containing Sugars in the Epidemics of Obesity and Metabolic Syndrome
Stanhope, K. L. (2012) · Annual Review of Medicine · doi:10.1146/annurev-med-042010-113026 · Cited by 220
The Effects of Fructose Intake on Serum Uric Acid Vary among Controlled Dietary Trials
Wang, D. D., Sievenpiper, J. L., de Souza, R. J., Chiavaroli, L., Ha, V., Cozma, A. I., Mirrahimi, A., Yu, M. E., Carleton, A. J., Buono, M. D., et al. (2012) · The Journal of Nutrition · doi:10.3945/jn.111.151951 · Cited by 218
Fructose and the Metabolic Syndrome: Pathophysiology and Molecular Mechanisms
Rutledge, A. C., & Adeli, K. (2007) · Nutrition Reviews · doi:10.1301/nr.2007.jun.s13-s23 · Cited by 215
ChREBP regulates fructose-induced glucose production independently of insulin signaling
Kim, M.-S., Krawczyk, S. A., Doridot, L., Fowler, A. J., Wang, J. X., Trauger, S. A., Noh, H.-L., Kang, H. J., Meissen, J. K., Blatnik, M., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci81993 · Cited by 212 · cited 2×
“ChREBP regulates fructose-induced glucose production independently of insulin signaling [22], and the fructose-induced increases in circulating fibroblast growth factor 21 (FGF21) [55].”
BackgroundSevastianova, K., Santos, A., Kotronen, A., Hakkarainen, A., Makkonen, J., Silander, K., Peltonen, M., Romeo, S., Lundbom, J., Lundbom, N., et al. (2012) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.112.038695 · Cited by 211
Sugar-sweetened beverage, diet soda, and fatty liver disease in the Framingham Heart Study cohorts
Ma, J., Fox, C. S., Jacques, P. F., Speliotes, E. K., Hoffmann, U., Smith, C. E., Saltzman, E., & McKeown, N. M. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.03.032 · Cited by 211
Expression of fatty acid synthase in nonalcoholic fatty liver disease
Dorn, C., Riener, M., Kirovski, G., Saugspier, M., Steib, K., Weiß, T. S., Gäbele, E., Kristiansen, G., Hartmann, A., & Hellerbrand, C. (2010) · PubMed · doi:10.5283/epub.37047 · Cited by 202
Obesity and cardiovascular disease: friend or foe?
Kim, S. H., Després, J.-P., & Koh, K. K. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehv509 · Cited by 201
De novo lipogenesis in metabolic homeostasis: More friend than foe?
Solinas, G., Borén, J., & Dulloo, A. G. (2015) · Molecular Metabolism · doi:10.1016/j.molmet.2015.03.004 · Cited by 197
Self-citationJohnston, R. D., Stephenson, M. C., Crossland, H., Cordon, S. M., Palcidi, E., Cox, E. F., Taylor, M. A., Aithal, G. P., & Macdonald, I. A. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.07.012 · Cited by 193
Abdelmalek, M. F., Lazo, M., Horska, A., Bonekamp, S., Lipkin, E. W., Balasubramanyam, A., Bantle, J. P., Johnson, R. J., Diehl, A. M., & Clark, J. M. (2012) · Hepatology · doi:10.1002/hep.25741 · Cited by 190
Sozen, E., & Ozer, N. K. (2017) · Redox Biology · doi:10.1016/j.redox.2017.02.025 · Cited by 187
Sirota, J. C., McFann, K., Targher, G., Johnson, R. J., Chonchol, M., & Jalal, D. I. (2013) · Metabolism · doi:10.1016/j.metabol.2012.08.013 · Cited by 184
Lambertz, J., Weiskirchen, S., Landert, S., & Weiskirchen, R. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01159 · Cited by 183
Metabolic health in normal-weight and obese individuals
Schulze, M. B. (2019) · Diabetologia · doi:10.1007/s00125-018-4787-8 · Cited by 182
Intestinal Absorption of Fructose
Ferraris, R. P., Choe, J.-Y., & Patel, C. R. (2018) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-082117-051707 · Cited by 180
Added Sugars Intake Across the Distribution of US Children and Adult Consumers: 1977-2012
Powell, E. S., Smith-Taillie, L. P., & Popkin, B. M. (2016) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2016.06.003 · Cited by 178
Johnson, R. K., Lichtenstein, A. H., Anderson, C. A. M., Carson, J. A., Després, J.-P., Hu, F. B., Kris-Etherton, P. M., Otten, J. J., Towfighi, A., Wylie-Rosett, J., et al. (2018) · Circulation · doi:10.1161/cir.0000000000000569 · Cited by 176 · cited 2×
“profiles to short term feeding of fructose as compared to glucose in both lean and obese subjects [8,53].”
BackgroundMitsuyoshi, H., Yasui, K., Harano, Y., Endo, M., Tsuji, K., Minami, M., Itoh, Y., Okanoue, T., & Yoshikawa, T. (2009) · Hepatology Research · doi:10.1111/j.1872-034x.2008.00464.x · Cited by 172
Silbernagel, G., Machann, J., Unmuth, S., Schick, F., Stefan, N., Häring, H. U., & Fritsche, A. (2011) · British Journal of Nutrition · doi:10.1017/s000711451000574x · Cited by 172
Fructose consumption: recent results and their potential implications
Stanhope, K. L., & Havel, P. J. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05266.x · Cited by 168
A critical role for ChREBP-mediated FGF21 secretion in hepatic fructose metabolism
Fisher, F. M., Kim, M., Doridot, L., Cunniff, J. C., Parker, T. S., Levine, D. M., Hellerstein, M. K., Hudgins, L. C., Maratos-Flier, E., & Herman, M. A. (2017) · Molecular Metabolism · doi:10.1016/j.molmet.2016.11.008 · Cited by 166 · cited 5×
“Consequently, circulating FGF21 levels correlate with rates of de novo lipogenesis in human subjects [55].”
BackgroundInfluentialSobrecases, H., Lê, K.-A., Bortolotti, M., Schneiter, P., Ith, M., Kreis, R., Boesch, C., & Tappy, L. (2010) · Diabetes & Metabolism · doi:10.1016/j.diabet.2010.03.003 · Cited by 161
Xu, C., Yu, C., Xu, L., Miao, M., & Li, Y. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011578 · Cited by 161
Cox, C. L., Stanhope, K. L., Schwarz, J. M., Graham, J. L., Hatcher, B., Griffen, S. C., Bremer, A. A., Berglund, L., McGahan, J. P., Keim, N. L., et al. (2012) · Nutrition & Metabolism · doi:10.1186/1743-7075-9-68 · Cited by 160
Effects of a short-term overfeeding with fructose or glucose in healthy young males
Sock, E. T. N., Lê, K., Ith, M., Kreis, R., Boesch, C., & Tappy, L. (2009) · British Journal Of Nutrition · doi:10.1017/s0007114509992819 · Cited by 157
Lonardo, A., Loria, P., Leonardi, F., Borsatti, A., Neri, P., Pulvirenti, M., Verrone, A. M., Bagni, A., Bertolotti, M., Ganazzi, D., et al. (2002) · Digestive and Liver Disease · doi:10.1016/s1590-8658(02)80194-3 · Cited by 146
Lecoultre, V., Egli, L., Carrel, G., Theytaz, F., Kreis, R., Schneiter, P., Boss, A., Zwygart, K., Lê, K., Bortolotti, M., et al. (2013) · Obesity · doi:10.1002/oby.20377 · Cited by 146
Taskinen, M., Söderlund, S., Bogl, L. H., Hakkarainen, A., Matikainen, N., Pietiläinen, K. H., Räsänen, S., Lundbom, N. M. I., Björnson, E., Eliasson, B., et al. (2017) · Journal of Internal Medicine · doi:10.1111/joim.12632 · Cited by 133
Self-citationCox, C. L., Stanhope, K. L., Schwarz, J. M., Graham, J. L., Hatcher, B., Griffen, S. C., Bremer, A. A., Berglund, L., McGahan, J. P., Havel, P. J., et al. (2012) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2011.159 · Cited by 132
Fructose-containing caloric sweeteners as a cause of obesity and metabolic disorders
Tappy, L. (2018) · Journal of Experimental Biology · doi:10.1242/jeb.164202 · Cited by 130
Liu, Z., Que, S., Zhou, L., & Zheng, S. (2015) · Scientific Reports · doi:10.1038/srep14325 · Cited by 127
Impact of fat mass and distribution on lipid turnover in human adipose tissue
Spalding, K. L., Bernard, S., Näslund, E. B., Salehpour, M., Possnert, G., Appelsved, L., Fu, K., Alkass, K., Druid, H., Thorell, A., et al. (2017) · Nature Communications · doi:10.1038/ncomms15253 · Cited by 122
Does nonalcoholic fatty liver disease cause cardiovascular disease? Current knowledge and gaps
Santos, R. D., Valenti, L. V. C., & Romeo, S. (2019) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2019.01.029 · Cited by 122
The Unfolded Protein Response in Fatty Liver Disease
Green, R. R., & Henkel, A. S. (2013) · Seminars in Liver Disease · doi:10.1055/s-0033-1358522 · Cited by 112
Crosstalk between nonalcoholic fatty liver disease and cardiometabolic syndrome
Lim, S. K., Taskinen, M., & Borén, J. (2018) · Obesity Reviews · doi:10.1111/obr.12820 · Cited by 111
Self-citationEmerging Evidence that ApoC-III Inhibitors Provide Novel Options to Reduce the Residual CVD
Taskinen, M., Packard, C. J., & Borén, J. (2019) · Current Atherosclerosis Reports · doi:10.1007/s11883-019-0791-9 · Cited by 110
Self-citationJegatheesan, P., Beutheu, S., Ventura, G., Sarfati, G., Nubret, E., Kapel, N., Waligora‐Dupriet, A., Bergheim, I., Cynober, L., & Bandt, J. P. D. (2015) · Clinical Nutrition · doi:10.1016/j.clnu.2015.01.021 · Cited by 108
Clinical assessment of hepatic de novo lipogenesis in non-alcoholic fatty liver disease
Paglialunga, S., & Dehn, C. A. (2016) · Lipids in Health and Disease · doi:10.1186/s12944-016-0321-5 · Cited by 108
Taskinen, M., & Borén, J. (2016) · Current Atherosclerosis Reports · doi:10.1007/s11883-016-0614-1 · Cited by 104
Self-citationFructose metabolism, cardiometabolic risk, and the epidemic of coronary artery disease
Mirtschink, P., Jang, C., Arany, Z. P., & Krek, W. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx518 · Cited by 104
Intestinal, but not hepatic, ChREBP is required for fructose tolerance
Kim, M.-S., Astapova, I. I., Flier, S. N., Hannou, S. A., Doridot, L., Sargsyan, A., Kou, H. H., Fowler, A. J., Liang, G., & Herman, M. A. (2017) · JCI Insight · doi:10.1172/jci.insight.96703 · Cited by 103
Stanhope, K. L., Goran, M. I., Bosy‐Westphal, A., King, J. C., Schmidt, L. A., Schwarz, J., Stice, E. M., Sylvetsky, A. C., Turnbaugh, P. J., Bray, G. A., et al. (2018) · Obesity Reviews · doi:10.1111/obr.12699 · Cited by 100
Yu, T. Y., Jee, J. H., Bae, J. C., Jin, S., Baek, J.-H., Lee, M., & Kim, J. H. (2015) · Metabolism · doi:10.1016/j.metabol.2015.11.003 · Cited by 98
Sun, H., Pei, D., Lue, K., & Chen, Y.-L. (2015) · PLoS ONE · doi:10.1371/journal.pone.0143786 · Cited by 98
Taee, F. A., Zerafati-Shoae, N., Dehghani, M., Sadeghi, M., Baradaran, H. R., & Jazayeri, S. (2018) · European Journal of Nutrition · doi:10.1007/s00394-018-1711-4 · Cited by 98
Patel, C., Douard, V., Yu, S., Gao, N., & Ferraris, R. P. (2015) · The FASEB Journal · doi:10.1096/fj.15-272195 · Cited by 97
Fructose and carbonyl metabolites as endogenous toxins
Lee, O., Bruce, W. R., Dong, Q., Bruce, J., Mehta, R., & O'Brien, P. J. (2008) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2008.10.011 · Cited by 95
Babió, N., Martínez‐González, M. Á., Estruch, R., Wärnberǵ, J., Recondo, J., Ortega‐Calvo, M., Serra‐Majem, L., Corella, D., Fitó, M., Ros, E., et al. (2014) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2014.10.006 · Cited by 94
Pickens, M., Yan, J. S., Ng, R., Ogata, H., Grenert, J. P., Beysen, C., Turner, S., & Maher, J. J. (2009) · Journal of Lipid Research · doi:10.1194/jlr.m900022-jlr200 · Cited by 94
Lee, J. W., Cho, Y. K., Ryan, M. C., Kim‡, H., Lee, S. W., Chang, E., Joo, K. J., Kim∥, J. T., Kim¶, B. S., & Sung, K. (2010) · Gut and Liver · doi:10.5009/gnl.2010.4.3.378 · Cited by 92
Theytaz, F., Noguchi, Y., Egli, L., Campos, V. C., Buehler, T., Hodson, L., Patterson, B. W., Nishikata, N., Kreis, R., Mittendorfer, B., et al. (2012) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.112.035139 · Cited by 82
Dietary carbohydrates and fatty liver disease: de novo lipogenesis
Chiu, S., Mulligan, K. M., & Schwarz, J. (2018) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000469 · Cited by 82
Dicarbonyl stress in clinical obesity
Masania, J., Malczewska-Malec, M., Raźny, U., Góralska, J., Zdzienicka, A., Kieć‐Wilk, B., Gruca, A., Stancel-Możwiłło, J., Dembinska-Kiec, A., Rabbani, N., et al. (2016) · Glycoconjugate Journal · doi:10.1007/s10719-016-9692-0 · Cited by 79
Francey, C., Cros, J., Rosset, R., Crézé, C., Rey, V., Stefanoni, N., Schneiter, P., Tappy, L., & Seyssel, K. (2018) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2018.11.008 · Cited by 79
Siqueira, J. H., Mill, J. G., Velásquez-Meléndez, G., Moreira, A. D., Barreto, S. M., Benseñor, I. M., & Molina, M. D. C. B. (2018) · Nutrients · doi:10.3390/nu10080981 · Cited by 78
Borén, J., Watts, G. F., Adiels, M., Söderlund, S., Chan, D. C., Hakkarainen, A., Lundbom, J., Lundbom, N., Matikainen, N., Kahri, J., et al. (2015) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.115.305614 · Cited by 72
Self-citationFructose at the crossroads of the metabolic syndrome and obesity epidemics
Gugliucci, A. (2018) · Frontiers in bioscience · doi:10.2741/4713 · Cited by 71
Recent insights into the role of ChREBP in intestinal fructose absorption and metabolism
Lee, H.-J., & Cha, J.-Y. (2018) · BMB Reports · doi:10.5483/bmbrep.2018.51.9.197 · Cited by 63
Moore, J. B. (2019) · Proceedings of The Nutrition Society · doi:10.1017/s0029665119000570 · Cited by 62
Novel Role of Enteral Monosaccharides in Intestinal Lipoprotein Production in Healthy Humans
Xiao, C., Dash, S., Morgantini, C., & Lewis, G. F. (2013) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.300769 · Cited by 61
Gugliucci, A., Lustig, R. H., Caccavello, R. J., Erkin‐Cakmak, A., Noworolski, S. M., Tai, V., Wen, M., Mulligan, K. M., & Schwarz, J. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.06.048 · Cited by 59
Role of apolipoprotein C-III overproduction in diabetic dyslipidaemia
Adiels, M., Taskinen, M., Björnson, E., Andersson, L., Matikainen, N., Söderlund, S., Kahri, J., Hakkarainen, A., Lundbom, N., Sihlbom, C., et al. (2019) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13744 · Cited by 55
Self-citationZurlo, A., Veronese, N., Giantin, V., Maselli, M., Zambon, S., Maggi, S., Musacchio, E., Toffanello, E. D., Sartori, L., Perissinotto, E., et al. (2015) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2015.10.007 · Cited by 44
Meneses‐León, J., Denova‐Gutiérrez, E., Castañón-Robles, S., Granados-García, V., Talavera, J. O., Rivera‐Paredez, B., Huitrón-Bravo, G. G., Cervantes‐Rodríguez, M., Quiterio-Trenado, M., Rudolph, S. E., et al. (2014) · BMC Public Health · doi:10.1186/1471-2458-14-445 · Cited by 43
French Recommendations for Sugar Intake in Adults: A Novel Approach Chosen by ANSES
Tappy, L., Morio, B., Azzout‐Marniche, D., Champ, M. M. J., Gerber, M., Houdart, S., Mas, E., Rizkalla, S. W., Slama, G., Mariotti, F., et al. (2018) · Nutrients · doi:10.3390/nu10080989 · Cited by 41
Yang, C., Yang, S., Xu, W., Zhang, J., Fu, W., & Feng, C. (2017) · PLoS ONE · doi:10.1371/journal.pone.0177249 · Cited by 40
Sangüesa, G., Shaligram, S. S., Akther, F., Roglans, N., Laguna, J. C., Rahimian, R., & Alegret, M. (2016) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00339.2016 · Cited by 34
Bae, J., Chun, B.-Y., Park, P.-S., Choi, B. Y., Kim, M. K., Shin, M., Lee, Y. H., Shin, D. H., & Kim, S. (2013) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2013.10.008 · Cited by 33
Dietary Fructose Metabolism By Splanchnic Organs: Size Matters
Gonzalez, J. T., & Betts, J. A. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.02.013 · Cited by 32
Piché, M., Vasan, S. K., Hodson, L., & Karpe, F. (2018) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000522 · Cited by 32
Erkin‐Cakmak, A., Bains, Y., Caccavello, R. J., Noworolski, S. M., Schwarz, J., Mulligan, K. M., Lustig, R. H., & Gugliucci, A. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-02772 · Cited by 32
Application of Magnetic Resonance Spectroscopy in metabolic research
van de Weijer, T., & Schrauwen‐Hinderling, V. B. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.09.013 · Cited by 25
Zhang, S., Du, T., Li, M., Lu, H., Lin, X., & Yu, X. (2017) · Medicine · doi:10.1097/md.0000000000006381 · Cited by 23
Surowska, A., Jegatheesan, P., Campos, V. C., Marques, A.-S., Egli, L., Cros, J., Rosset, R., Lecoultre, V., Kreis, R., Boesch, C., et al. (2019) · Nutrients · doi:10.3390/nu11010209 · Cited by 18
Sugar and Fatty Acids Ack-celerate Prophage Induction
Chatterjee, A., & Duerkop, B. A. (2019) · Cell Host & Microbe · doi:10.1016/j.chom.2019.01.012 · Cited by 16
HOFFMAN, S. S., ALVARES, D. C. L., & Adeli, K. (2019) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000569 · Cited by 16
A possible role of serum uric acid as a marker of metabolic syndrome
Lee, Y., Cho, S. Y., & Kim, S. R. (2014) · Internal Medicine Journal · doi:10.1111/imj.12588 · Cited by 15
More pieces of the fructose puzzle
Stanhope, K. L. (2017) · Journal of Internal Medicine · doi:10.1111/joim.12644 · Cited by 7
Cited by
Metabolic Syndrome: Past, Present and Future
Lemieux, I., & Després, J.-P. (2020) · Nutrients · doi:10.3390/nu12113501 · Cited by 309
The metabolic nature of inflammatory bowel diseases
Adolph, T. E., Meyer, M., Schwärzler, J., Mayr, L., Grabherr, F., & Tilg, H. (2022) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-022-00658-y · Cited by 296
Causes and consequences of hypertriglyceridemia
Packard, C. J., Boren, J., & Taskinen, M.-R. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00252 · Cited by 239
Self-citationThe Roles of ApoC-III on the Metabolism of Triglyceride-Rich Lipoproteins in Humans
Borén, J., Packard, C. J., & Taskinen, M.-R. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00474 · Cited by 196
“Fructose induced not only increased expression of APOC3 (111, 113), but also increased hepatic de novo lipogenesis of fatty acids that is an important initiator of NAFLD and overproduction of triglyceride-rich VLDL1 particles (43, 61, 118– 122).”
BackgroundSelf-citationMazhar, M., Zhu, Y., & Qin, L. (2023) · Foods · doi:10.3390/foods12051023 · Cited by 119
Metadata
- Authors
- Taskinen, M.-R., Packard, C. J., & Borén, J.
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2019-08-22
- Volume
- 11
- Issue
- 9
- Pages
- 1987
- ISSN
- 2072-6643 (ISSN-L)
- OpenAlex
- W2969993959
- Cited by
- 295
- References
- 152
- FWCI
- 22.03
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.